O
OrbiMed Portfolio holdings
AUM
$3.98B
This Quarter Return
+15.9%
1 Year Return
+13.05%
3 Year Return
+159.74%
5 Year Return
+207.27%
10 Year Return
+1,027.33%
AUM
$6.71B
AUM Growth
+$6.71B
(+24%)
Cap. Flow
+$780M
Cap. Flow
% of AUM
11.63%
Top 10 Holdings %
Top 10 Hldgs %
38.94%
Holding
137
New
19
Increased
49
Reduced
25
Closed
20
Top Buys
| 1 |
RLYP
RELYPSA INC COM
RLYP
|
$249M |
| 2 |
Perrigo
PRGO
|
$119M |
| 3 |
AbbVie
ABBV
|
$107M |
| 4 |
XLRN
Acceleron Pharma Inc.
XLRN
|
$83.9M |
| 5 |
CELG
Celgene Corp
CELG
|
$76.1M |
Top Sells
| 1 |
Merck
MRK
|
$177M |
| 2 |
Elevance Health
ELV
|
$71.8M |
| 3 |
WCRX
WARNER CHILCOTT PLC ORD SHS CL A (IRL)
WCRX
|
$56.2M |
| 4 |
CBST
CUBIST PHARMACEUTICALS INC
CBST
|
$56.1M |
| 5 |
SPDR S&P 500 ETF Trust
SPY
|
$50.4M |
Sector Composition
| 1 | Healthcare | 84.81% |
| 2 | Financials | 1.2% |
| 3 | Technology | 0.1% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
ESRX
26
DELISTED
Express Scripts Holding Company
ESRX
| $90.4M | 1.33% |
1,287,000
-496,000
| -28% | -$34.8M |
|
|
CFN
27
DELISTED
CAREFUSION CORPORATION
CFN
| $86.5M | 1.27% |
2,171,500
+968,200
| +80% | +$38.6M |
|
|
AGN
28
DELISTED
ALLERGAN INC
AGN
| $86.1M | 1.27% |
775,200
+478,200
| +161% | +$53.1M |
|
|
XLRN
29
DELISTED
Acceleron Pharma Inc.
XLRN
| $83.9M | 1.23% |
+2,117,648
| New | +$83.9M |
|
|
AET
30
DELISTED
Aetna Inc
AET
| $80.5M | 1.18% |
1,173,100
-379,900
| -24% | -$26.1M |
|
31
Zimmer Biomet
ZBH
$20.8B
| $77.8M | 1.14% |
835,200
+790,200
| +1,756% | +$73.6M |
|
32
Molina Healthcare
MOH
$9.6B
| $71.7M | 1.05% |
2,063,100
+229,100
| +12% | +$7.96M |
|
|
INFI
33
DELISTED
Infinity Pharmaceuticals, Inc.
INFI
| $66.2M | 0.97% |
4,794,300
+201,700
| +4% | +$2.79M |
|
34
UnitedHealth
UNH
$279B
| $59.6M | 0.88% |
791,000
-538,000
| -40% | -$40.5M |
|
35
Exact Sciences
EXAS
$9.33B
| $58.6M | 0.86% |
4,989,300
+309,000
| +7% | +$3.63M |
|
|
AFFX
36
DELISTED
AFFYMETRIX INC
AFFX
| $58.4M | 0.86% |
6,810,000
+162,000
| +2% | +$1.39M |
|
37
Exelixis
EXEL
$9.95B
| $57.6M | 0.85% |
9,389,000
+645,000
| +7% | +$3.95M |
|
38
Johnson & Johnson
JNJ
$429B
| $57.3M | 0.84% |
626,000
-27,000
| -4% | -$2.47M |
|
39
McKesson
MCK
$85.9B
| $57.3M | 0.84% |
355,000
+279,000
| +367% | +$45M |
|
40
Standard BioTools
LAB
$493M
| $55.4M | 0.81% |
1,446,008
+29,400
| +2% | +$1.13M |
|
41
Stryker
SYK
$149B
| $53.9M | 0.79% |
716,700
+650,700
| +986% | +$48.9M |
|
|
STJ
42
DELISTED
St Jude Medical
STJ
| $51.6M | 0.76% |
833,600
+713,600
| +595% | +$44.2M |
|
|
HNT
43
DELISTED
HEALTH NET INC
HNT
| $46.3M | 0.68% |
1,561,400
+291,800
| +23% | +$8.66M |
|
|
QGENF
44
DELISTED
QIAGEN NV
QGENF
| $45.9M | 0.67% |
+1,927,000
| New | +$45.9M |
|
|
45
Elevance Health
ELV
$72.4B
| $39.6M | 0.58% |
429,000
-777,000
| -64% | -$71.8M |
|
46
Prothena Corp
PRTA
$452M
| $31.9M | 0.47% |
+1,202,000
| New | +$31.9M |
|
47
Celldex Therapeutics
CLDX
$1.57B
| $31.7M | 0.47% |
+1,310,600
| New | +$31.7M |
|
48
OraSure Technologies
OSUR
$230M
| $31.4M | 0.46% |
4,988,000
+127,900
| +3% | +$805K |
|
|
ALXN
49
DELISTED
Alexion Pharmaceuticals Inc
ALXN
| $30.9M | 0.45% |
232,900
+17,000
| +8% | +$2.26M |
|
50
Intuitive Surgical
ISRG
$158B
| $28.6M | 0.42% |
+74,500
| New | +$28.6M |
|